Literature DB >> 21372488

Does the bromocriptine-rebound method improve embryo quality?

Naoko Moride1, Akira Kuwahara, Mizuho Yamashita, Yu Tanaka, Toshiya Matsuzaki, Toshiyuki Yasui, Minoru Irahara.   

Abstract

AIM: To examine whether the bromocriptine-rebound (BR) method improves pregnancy outcomes after previous unsuccessful assisted reproductive technology (ART) attempts. PATIENTS/STUDY
DESIGN: In this study we retrospectively analyzed data from a total of 121 women with normal serum prolactin (PRL) levels and a history of repeated unsuccessful ART procedures. Pregnancy outcomes and hormonal data were compared between the long protocol and BR method. Both procedures were similar, except that in the BR method, bromocriptine was administered daily from day 5 of the preceding cycle until 7 days before ovarian stimulation.
RESULTS: The number of fertilized oocytes, cleaved embryos and transplant embryos were significantly higher with the BR method than with the long protocol even though the numbers of retrieved oocyte were same in both groups. The ratio of the good embryos, the clinical pregnancy rate was higher with the BR method than with the long protocol. The embryo score with the BR method were significantly higher than that with the long protocol.
CONCLUSION: BR method could provide the better embryos and improve the transplantation rate in women with previous unsuccessful ART attempts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372488     DOI: 10.2152/jmi.58.63

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  2 in total

1.  Changes in serum prolactin level during intracytoplasmic sperm injection, and effect on clinical pregnancy rate: a prospective observational study.

Authors:  Ahmed Kamel; Ayman A Halim; Mohamed Shehata; Salwa AlFarra; Yahia El-Faissal; Wafaa Ramadan; Ahmed M Hussein
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-09       Impact factor: 3.007

2.  Mildly Higher Serum Prolactin Levels Are Directly Proportional to Cumulative Pregnancy Outcomes in in-vitro Fertilization/Intracytoplasmic Sperm Injection Cycles.

Authors:  Duoduo Zhang; Xi Yuan; Jingran Zhen; Zhengyi Sun; Chengyan Deng; Qi Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.